Description
Artemether & Lumefantrine Oral Suspension (Dry Syrup)
Healthy Inc is a specialized global supplier and exporter of advanced anti-malarials, tropical medicine, and pediatric therapeutics. We provide ultra-high-purity, kinetically stabilized Artemether & Lumefantrine Dry Syrup, manufactured in WHO–GMP certified, high-precision facilities. This “Artemisinin-based Combination Therapy (ACT)” is a massive-volume strategic export to public health organizations, African health ministries, and retail pharmacy chains, serving as the globally mandated intervention for the rapid treatment of acute, uncomplicated malaria.
Product Overview
This formulation operates as a “Rapid-Clearance and Long-Term Suppression System.” It physically targets the parasite at different stages of its life cycle in the blood to ensure a 95%+ cure rate.
Mechanism 1 (The Rapid Strike – Artemether): A semi-synthetic derivative of artemisinin. It physically reacts with the iron in the parasite’s heme, creating Free Radicals that physically destroy the parasite’s membranes. It provides the fastest reduction of parasite biomass in the first 24 hours.
Mechanism 2 (The Long-Term Guard – Lumefantrine): A synthetic antimalarial that physically interferes with the parasite’s ability to detoxify heme. It has a much longer half-life, staying in the blood to chemically eliminate any remaining parasites that survived the initial Artemether strike.
Mechanism 3 (Resistance Prevention): By combining a fast-acting agent with a long-acting one, the formula physically prevents the development of drug-resistant malaria strains.
Product Composition & Strength
We supply this product as Dry Powder for Reconstitution, ensuring maximum active ingredient stability in high-heat tropical zones.
| Active Ingredient | Strength (per 5ml reconstituted) | Primary Clinical Function |
| Artemether IP/BP | 15 mg / 20 mg | The Fast Killer: Provides rapid symptomatic relief. |
| Lumefantrine IP/BP | 90 mg / 120 mg | The Mop-up Agent: Prevents recurrence and resistance. |
| Excipients | Xanthan Gum / Sucrose | The Suspension Matrix: Ensures uniform dosage. |
| Flavoring | Mixed Fruit / Tutti-Frutti | The Palatable Base: Essential for pediatric compliance. |
Technical & Logistics Specifications
HS Code: 3004.20.19 (Medicaments containing other antibiotics – Anti-malarial)
CAS Numbers: 71963-77-4 (Artemether) / 82186-77-4 (Lumefantrine)
Dosage Form: Dry Powder for Oral Suspension
Packaging: 30ml / 60ml HDPE Bottles with measuring cups. Our specialized “Dry-Fill” packaging ensures 36-month stability in Zone IVb tropical climates.
Manufacturing Authority & Compliance
High-Stability Granulation: We utilize Advanced Fluid Bed Drying to create moisture-resistant granules. This is critical because Artemether is physically sensitive to degradation; our process ensures it remains 100% potent until the point of use.
Aseptic Filling Excellence: We utilize Automated Vacuum Dry-Filling Lines with humidity-controlled environments (RH < 20%) to ensure the active ACT components do not degrade during manufacturing.
Bioavailability Optimization: We utilize Micronized Lumefantrine to ensure the drug, which is naturally poorly soluble, is physically ready for rapid absorption in the pediatric gut.
Primary Indications
Tropical Medicine: First-line treatment for Uncomplicated Malaria caused by P. falciparum.
Pediatrics: Preferred ACT for children and infants weighing 5kg and above.
Public Health: Primary tool for National Malaria Eradication Programs and emergency NGO relief.
Dosage & Administration
Standard Regimen: Typically a 6-dose regimen over 3 days. The dosage is physically calculated based on the child’s body weight (e.g., 5-15kg, 15-25kg).
Administration (CRITICAL): For maximum absorption, the suspension must be physically taken with high-fat food or milk. This increases Lumefantrine absorption by up to 16 times.
Reconstitution: Add boiled and cooled water up to the mark. Shake vigorously.
Safety Warning: For Oral Use Only. Malaria Warning: Do not use for the prevention of malaria (prophylaxis); use only for treatment. Severe Case Note: Not for the treatment of Cerebral Malaria or complicated cases; those require IV Artesunate. Contraindication: Do not use in the first trimester of pregnancy unless no other alternative is available.
Global Export & Contract Manufacturing
Healthy Inc is a premier Anti-Malarial and Public Health Pharmaceutical Exporter in India. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) for high-volume ACT suspensions. Whether you are a National Malaria Program in Africa or a B2B Pharma Marketplace partner in SE Asia or LATAM, we ensure secure, WHO-GMP compliant delivery.
Reviews
There are no reviews yet.